Fig. 4From: Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomicsReprogramming of energy metabolism associated with cancer growth detected in plasma in a murine model of 4T1 metastatic breast cancer. Increase in glycolytic rate, evidenced as an increase of hexose phosphate (a), fructose 1,6-bisphosphate (b), glyceraldehyde 3-phosphate and dihydroxyacetone phosphate (c) concentrations measured in plasma, and a decrease of tricarboxylic acid cycle intermediate plasma concentrations of succinate (d) and fumarate (e). Increase of glutamine catabolism evidenced as an increase in glutamate-to-glutamine ratio (f) and acceleration of pentose phosphate pathway increase of erythrose 4-phosphate (g) and pentose phosphate concentrations (h). A simplified overview of 4T1 breast cancer-induced changes in energy metabolism (i). Empty bars represent control animals, and black bars represent tumour-bearing mice. Data are expressed as mean ± SEM (n = 10). The data were analysed with either analysis of variance (ANOVA) followed by Tukey’s post hoc test (GADP_DHAP, fumarate, Gln/Glu) or a non-parametric Kruskal-Wallis ANOVA (Hexose-P, fructose 1,6-bisphosphate, succinate, E4P, Pentose-5P), depending on the normality of distribution and variance homogeneity (F test), with statistical significance set at *p < 0.05, **p < 0.01, ***p < 0.001Back to article page